Mr. Rene Goehrum reports

BIOSYENT PHARMA LAUNCHES NEW FERAMAX(R) POWDER-WATER SOLUBLE POLYSACCHARIDE-IRON COMPLEX IRON SUPPLEMENT

BioSyent Inc.'s subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of its unique new oral iron supplement -- FeraMAX powder.

FeraMAX powder is the first innovation in the pediatric oral iron market in Canada in almost 50 years. The Canadian market launch will be the global introduction of this new product and provides BioSyent Pharma with a unique offering for international marketing partners.

FeraMAX powder joins FeraMAX 150 in providing health care professionals and their patients with a safe, effective and well-tolerated oral iron supplement. It is indicated for the prevention of iron deficiency and iron deficiency anemia in newborns, infants, children and adults.

FeraMAX powder is the only oral iron product available in a dissolvable powder and comes in pleasant-tasting grape/raspberry flavoured gluten and alcohol-free crystals which can be conveniently dosed by diluting in water or mixing with soft foods. This innovative new product is based upon the same doctor recommended, proprietary, non-ionic polysaccharide-iron complex technology found in FeraMAX 150.

Other oral iron products intended for infants and children either have an unpleasant heavy metallic taste which deter patient compliance or they come in formulations containing alcohol which health care professionals and caregivers prefer to avoid. In addition to its clear advantages in the pediatric market, FeraMAX powder is also well suited for adult patients that have difficulty swallowing pills.

FeraMAX powder was exhibited at the recent Primary Care Today medical conference attended by over 3,000 health care professionals. Listings have been secured at major wholesalers and shipments of FeraMAX powder, to over 30 wholesale distribution centres supplying pharmacies across Canada, will commence over the next week.

"The launch of FeraMAX powder further strengthens BioSyent Pharma's leadership position in providing innovative iron supplement solutions for health care professionals and their patients," said Rene Goehrum, president and chief executive officer of BioSyent. "We now have a full range of solutions and dosing options available for all iron deficient and iron deficient anemia patients."

For more information regarding FeraMAX Powder and FeraMAX 150, visit the FeraMAX website.

We seek Safe Harbor.